Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung.

BACKGROUND: The variable efficacy (0-80%) of Mycobacterium bovis Bacille Calmette Guréin (BCG) vaccine against adult tuberculosis (TB) necessitates development of alternative vaccine candidates. Development of recombinant BCG (rBCG) over-expressing promising immunodominant antigens of M. tuberculosi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ruchi Jain, Bappaditya Dey, Neeraj Dhar, Vivek Rao, Ramandeep Singh, Umesh D Gupta, V M Katoch, V D Ramanathan, Anil K Tyagi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science (PLoS) 2008-01-01
Reeks:PLoS ONE
Online toegang:http://europepmc.org/articles/PMC2586085?pdf=render
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items